Picture of Chemring logo

CHG Chemring News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsBalancedMid CapHigh Flyer

REG - Chemring Group PLC - Norwegian feasibility study

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250626:nRSZ5290Oa&default-theme=true

RNS Number : 5290O  Chemring Group PLC  26 June 2025

FOR IMMEDIATE RELEASE
 
           26 JUNE 2025

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

NORWEGIAN FEASIBILITY STUDY MOVES TO SECOND STAGE

 

Chemring's 2025 interim results announcement, published on 3 June, provided an
update on the joint feasibility study between the Norwegian Government and
Chemring Nobel, Chemring's Norwegian subsidiary. This study, which commenced
in October 2024, was initiated to assess the feasibility of an additional new
production facility to significantly increase the production of military
explosives, which are crucial to multiple NATO missile and munitions systems.

 

The first phase of this co-funded feasibility study investigated the
geographic location, infrastructure requirements and environmental
considerations of building a new production facility.

 

Chemring is pleased to announce that the Norwegian Government has confirmed
that the study will now progress to its second phase. This concept selection
phase will determine the size of the facility, along with the commercial
arrangements, and is expected to be finalised next year.

 

Michael Ord, Chief Executive of Chemring, commented:

 

"We are delighted that the Norwegian Government has confirmed that this
important study will continue to the next phase. This decision is a further
indicator of the critical need to rapidly increase capacity across the
European defence industrial base.

"This decision is further evidence of Chemring delivering its strategy of
delivering growth through a combination of organic investment and bolt-on
acquisitions in high-priority defence and national security markets."

ENDS

 

 

For further information:

Rupert Pittman           Group Director of Corporate Affairs,
             01794 463401

                                       Chemring Group
PLC

 

James McFarlane        MHP
Group
                        07584 142665

Ollie Hoare
 
         07817 458804

 

 

Cautionary statement

 

This announcement contains forward-looking statements that are based on
current expectations or beliefs, as well as assumptions about future events.
These forward-looking statements can be identified by the fact that they do
not relate only to historical or current facts. Forward-looking statements
often use words such as anticipate, target, expect, estimate, intend, plan,
goal, believe, will, may, should, would, could, is confident, or other words
of similar meaning. Undue reliance should not be placed on any such statements
because they speak only as at the date of this document and, by their very
nature, they are subject to known and unknown risks and uncertainties and can
be affected by other factors that could cause actual results, and Chemring's
plans and objectives, to differ materially from those expressed or implied in
the forward-looking statements. There are a number of factors which could
cause actual results to differ materially from those expressed or implied in
forward-looking statements. Among the factors that could cause actual results
to differ materially from those described in the forward-looking statements
are: increased competition, the loss of or damage to one or more key customer
relationships, changes to customer ordering patterns, delays in obtaining
customer approvals for engineering or price level changes, the failure of one
or more key suppliers, the outcome of business or industry restructuring, the
outcome of any litigation, changes in economic conditions, currency
fluctuations, changes in interest and tax rates, changes in raw material or
energy market prices, changes in laws, regulations or regulatory policies,
developments in legal or public policy doctrines, technological developments,
the failure to retain key management, or the key timing and success of future
acquisition opportunities or major investment projects. Chemring undertakes no
obligation to revise or update any forward-looking statement contained within
this announcement, regardless of whether those statements are affected as a
result of new information, future events or otherwise, save as required by law
and regulations.

 

Notes to editors

 

·   Chemring is a FTSE250 global business that specialises in the
manufacture of high technology products and the provision of services to the
defence, aerospace and security markets

·   Employing approximately 2,700 people worldwide, and with production
facilities in four countries, Chemring meets the needs of customers in more
than fifty countries

·   Chemring is organised under two strategic product segments: Sensors
& Information and Countermeasures & Energetics

·   Chemring has a diverse portfolio of products that deliver high
reliability solutions to protect people, platforms, missions and information
against constantly changing threats

·   Operating in niche markets and with strong investment in research and
development ("R&D"), Chemring has the agility to rapidly react to urgent
customer needs

 

www.chemring.com. (http://www.chemring.com.)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STREQLBLEQLLBBB

Recent news on Chemring

See all news